Evaluation of strategies of care in the secondary prevention of heart disease: critical appraisal of a cluster randomized trial.
暂无分享,去创建一个
[1] J. Newell,et al. Effect of tailored practice and patient care plans on secondary prevention of heart disease in general practice: cluster randomised controlled trial , 2009, BMJ : British Medical Journal.
[2] Ching Choi,et al. World Health Statistics 2007 [Book Review] , 2008 .
[3] Shah Ebrahim,et al. Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) , 2007 .
[4] L. Tavazzi,et al. GlObal Secondary Prevention strategiEs to Limit event recurrence after myocardial infarction: the GOSPEL study. A trial from the Italian Cardiac Rehabilitation Network: rationale and design , 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[5] Lisa Hartling,et al. Meta-Analysis: Secondary Prevention Programs for Patients with Coronary Artery Disease , 2005, Annals of Internal Medicine.
[6] G. Backer. Evidence-based goals versus achievement in clinical practice in secondary prevention of coronary heart disease: findings in EUROASPIRE II , 2002 .
[7] P. Armstrong,et al. Randomised trials of secondary prevention programmes in coronary heart disease: systematic review , 2001, BMJ : British Medical Journal.
[8] G. Schuler,et al. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise. , 1997, Circulation.
[9] R. Brand,et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial , 1990, The Lancet.
[10] R. Ferrari,et al. Cardiovascular Disease Prevention in Clinical Practice , 2010 .
[11] Shah Ebrahim,et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. , 2007, Atherosclerosis.
[12] G. De Backer. Evidence-based goals versus achievement in clinical practice in secondary prevention of coronary heart disease: findings in EUROASPIRE II. , 2002, Atherosclerosis. Supplements.
[13] F. Palace,et al. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries , 2001 .